GenoMed submits 50th provisional patent application.GenoMed, Inc. (St. Louis, MO) announced that the company has submitted its 50th provisional patent application, a major milestone in any development stage company. GenoMed has so far been awarded two patents, one for treating acute kidney failure Acute Kidney Failure Definition Acute kidney failure occurs when illness, infection, or injury damages the kidneys. Temporarily, the kidneys cannot adequately remove fluids and wastes from the body or maintain the proper level of certain without dialysis, and another for hastening lung maturation in prematurely born infants. Two of the most recently submitted patent applications include a drug delivery system whereby the delivery of drugs to the bloodstream is controlled through specially formulated toothpastes, and a method to reduce scarring and fibrosis both on the skin and in internal organs. Small proteins like insulin don't survive the strong acid environment of the stomach, and must be injected to get into the bloodstream. As a result, patients with diabetes have to inject themselves under the skin one to three times a day. Putting insulin in toothpaste may be an effective method to get insulin into the bloodstream directly, especially after flossing flossing, n the mechanical cleansing of interproximal tooth surfaces with stringlike, waxed or unwaxed dental floss or tape. flossing aids, n. , which often causes bleeding of the gums. It may be especially useful for patients with juvenile-onset diabetes juvenile-onset diabetes n. Insulin-dependent diabetes. , who must begin injecting insulin as pre-teens. GenoMed's method to reduce scarring, both on the skin and in internal organs, involves another novel use for angiotensin angiotensin /an·gio·ten·sin/ (-ten´sin) a decapeptide hormone (a. I) formed from the plasma glycoprotein angiotensinogen by renin secreted by the juxtaglomerular apparatus. I-converting enzyme (ACE) inhibitors and angiotensin II angiotensin II n. An octapeptide that is a potent vasopressor and a powerful stimulus for production and release of aldosterone from the adrenal cortex. receptor blockers (ARBs) either as pills, which already exist, or as topical creams. This approach may be useful in dermatology and plastic surgery, especially for burn victims who get extensive scarring, patients with keloid keloid /ke·loid/ (ke´loid) a sharply elevated, irregularly shaped, progressively enlarging scar due to excessive collagen formation in the dermis during connective tissue repair. scars, etc. GenoMed is currently looking for partners to help develop its toothpaste drug delivery system, as well as patients with scars or fibrosis of internal organs for clinical trials. Please contact GenoMed's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Chief Medical Officer, David Moskowitz MD, at dwmoskowitz@genomed.com. GenoMed is a Next Generation DM company whose mission is to improve patient outcomes as quickly, safely, and inexpensively as possible by identifying the molecular pathways that cause disease. Disease Management (DM) is the only business in healthcare which profits by lowering healthcare costs. GenoMed is the only Disease Management company to use cutting-edge medical genomics to keep patients healthier and out of the hospital. GenoMed, Inc. +1-314-983-9933 www.genomedics.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion